Foci Pharmaceuticals: Announcement on providing guarantees for wholly-owned subsidiaries
Foci Pharmaceuticals: 2024 Semi-Annual Financial Report
Foci Pharmaceuticals: Semi-Annual Summary of Non-operating Capital Utilization and Other Related Capital Transactions
Lanzhou Foci Pharmaceutical: Legal opinion of Gansu Jincheng Law Firm on the second interim shareholders' meeting of Lanzhou Foci Pharmaceutical Co., Ltd. in 2024.
Lanzhou Foci Pharmaceutical: Announcement regarding the completion of the board of directors and the supervisory board's election and appointment of senior management personnel.
Lanzhou Foci Pharmaceutical: Announcement Regarding the Election of Employee Representatives of the Eighth Supervisory Board
Lanzhou Foci Pharmaceutical: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Lanzhou Foci Pharmaceutical: Notice Regarding the Second Extraordinary Shareholder Meeting in 2024 (Updated)
Lanzhou Foci Pharmaceutical: Announcement on the Election of the Supervisory Board
Lanzhou Foci Pharmaceutical: Notice of the Second Extraordinary Shareholders' Meeting in 2024 (before the update)
Lanzhou Foci Pharmaceutical: Announcement Regarding the Board of Directors' Election.
Lanzhou Foci Pharmaceutical: Announcement on Appointing Mr. Qian Shuangxi as Executive Vice President and Authorizing him to Exercise the Power of General Manager.
Lanzhou Foci Pharmaceutical: Announcement on the election of the Chairman of the Board and the by-election of members of the Professional Committee of the Board
Lanzhou Foci Pharmaceutical: Legal Opinions of Beijing Deheng (Lanzhou) Law Firm on the 2023 Annual General Meeting of Shareholders of Lanzhou Foci Pharmaceutical Co., Ltd.
Lanzhou Foci Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Foci Pharmaceuticals: Announcement on the Merger of Companies Under the Same Control and Retroactive Adjustment of Financial Data
Foci Pharmaceuticals: Notice on Requesting the Shareholders' Meeting to Authorize the Board of Directors to Issue Shares to Specific Targets through Simplified Procedures
Foci Pharmaceuticals: “Shareholder Return Plan for the Next Three Years (2024-2026)”
Foci Pharmaceuticals: Announcement on the Resignation of the Chairman of the Board and By-election of Non-Independent Directors
Foci Pharmaceuticals: General Manager Work Rules (April 2024)
No Data
No Data